Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

N-(2-chloro-6-methylphenyl)-2[(2-methylpyrimidine-4-group) amino] thiazole-5-formamide compound as well as preparation method and application thereof

A formamide compound, methyl phenyl technology, applied in the field of drug synthesis

Inactive Publication Date: 2014-11-19
FUDAN UNIV
View PDF5 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] Although the above two BCR-ABL kinase inhibitors have shown good curative effect, due to the increasing drug resistance and the differences between individuals in the treatment population, researchers in the industry are required to continuously research and develop new safe and effective small molecules Compounds to inhibit ABL kinase

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • N-(2-chloro-6-methylphenyl)-2[(2-methylpyrimidine-4-group) amino] thiazole-5-formamide compound as well as preparation method and application thereof
  • N-(2-chloro-6-methylphenyl)-2[(2-methylpyrimidine-4-group) amino] thiazole-5-formamide compound as well as preparation method and application thereof
  • N-(2-chloro-6-methylphenyl)-2[(2-methylpyrimidine-4-group) amino] thiazole-5-formamide compound as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] Embodiment 1: synthetic compound 1 , N-(2-chloro-6-methylphenyl)-2-[[2-methyl-6-(2-oxa-6-azaspiro[3.3]heptane-6-yl)pyrimidine- 4-yl]amino]thiazole-5-carboxamide

[0044] Under stirring at room temperature, 2-((6-chloro-2-methylpyrimidin-4-yl)amino )-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide (0.3 g, 0.76 mmol) and N,N-diisopropylethylamine (0.56 mL, 1.6 mmol) In 4-dioxane (10 mL) solution, the temperature was raised to reflux, and the reaction was carried out overnight, and the disappearance of the starting material was monitored by TLC. The reaction was stopped and cooled down to room temperature, and the solvent was removed. The obtained solid was washed twice with methanol and diethyl ether, respectively, and subjected to column chromatography to obtain a white solid (20 mg, yield 6%). 1 H NMR (400 MHz, DMSO- d 6) δ 11.47 (br s, 1H), 9.88 (s, 1H), 8.22 (s, 1H), 7.40 (dd, J = 7.5, 1.6 Hz, 1H), 7.35 – 7.20 (m, 2H), 5.69 (s, 1H), 4.72 (s, 4H), 4.15 (s, 4H)...

Embodiment 2

[0046] Embodiment 2: synthetic compound 2 , N-(2-chloro-6-methylphenyl)-2-[[2-methyl-6-(2-thia-6-azaspiro[3.3]heptane-6-yl)pyrimidine- 4-yl]amino]thiazole-5-carboxamide

[0047] Under stirring at room temperature, 2-thio-6azaspiro[3,3]heptane oxalate (128 mg, 0.4 mmol) was added to 2-((6-chloro-2-methylpyrimidin-4-yl)amino) 1,4- In dioxane (5 mL) solution, the temperature was raised to reflux, and the reaction was carried out overnight, and the disappearance of the starting material was monitored by TLC. The reaction was stopped and cooled to room temperature, and the solvent was removed. The obtained solid was washed twice with methanol and diethyl ether, respectively, and subjected to column chromatography to obtain a white solid (10 mg, yield 5%). 1 H NMR (400 MHz, DMSO- d 6) δ 11.49 (s, 1H), 9.89 (s, 1H), 8.22 (s, 1H), 7.40 (dd, J = 7.2, 1.2 Hz, 1H), 7.34 – 7.19 (m, 2H), 5.69 (s, 1H), 4.04 (s, 4H), 3.40 (s, 4H), 2.40 (s, 3H), 2.24 (s, 3H).

[0048]

Embodiment 3

[0049] Example 3: Synthetic compound 3, N-(2-chloro-6-methylphenyl)-2-[[2-methyl-6-(2-oxo-2-thia-6-azaspiro[ 3.3] Heptane-6-yl)pyrimidin-4-yl]amino]thiazole-5-carboxamide

[0050] Under stirring at room temperature, 2-oxa-6-thiaspiro[3.3]heptane-6-oxide oxalate (55, 359 mg, 1.02 mmol) was added to 2-((6-chloro-2-methyl Pyrimidin-4-yl)amino)-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide (52, 200 mg, 0.51 mmol) and N,N-diisopropylethylamine (0.356 mL, 2.04 mmol) in a solution of 1,4-dioxane (5 mL), heated to reflux, reacted overnight, and TLC monitored the disappearance of the starting material. The reaction was stopped and cooled to room temperature, the solvent was removed, and the obtained solid was washed twice with methanol and diethyl ether, and separated and prepared by high performance liquid chromatography to obtain a light yellow solid (10 mg, yield 4%). 1 H NMR (400 MHz, DMSO- d 6) δ 11.50 (s, 1H), 9.89 (s, 1H), 8.23 ​​(s, 1H), 7.40 (dd, J = 7.6, 1.6 Hz, 1H)...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of medicament synthesis, relates to an N-(2-chloro-6-methylphenyl)-2[(2-methylpyrimidine-4-group) amino] thiazole-5-formamide compound shown in a general formula (b), and in particular relates to a pyrimidine 6-bit four-membered heterocyclic ring or spiro ring substituted N-(2-chloro-6-methylphenyl)-2[(2-methylpyrimidine-4-group) amino] thiazole-5-formamide compound, a preparation method of the pyrimidine 6-bit four-membered heterocyclic ring or spiro ring substituted N-(2-chloro-6-methylphenyl)-2[(2-methylpyrimidine-4-group) amino] thiazole-5-formamide compound, and an application of the pyrimidine 6-bit four-membered heterocyclic ring or spiro ring substituted N-(2-chloro-6-methylphenyl)-2[(2-methylpyrimidine-4-group) amino] thiazole-5-formamide compound in medical science. The compound disclosed by the invention is subjected to in-vitro ABL kinase inhibitory activity and anti-tumor activity tests, and results show that the compound has good ABL kinase inhibitory activity and anti-tumor activity and can be further used for preparing a new anti-tumor medicament.

Description

technical field [0001] The invention belongs to the field of drug synthesis and relates to a new N -(2-Chloro-6-methylphenyl)-2[(2-methylpyrimidin-4-yl)amino]thiazole-5-carboxamide compound, preparation method and application. It specifically relates to a pyrimidine 6-position four-membered heterocycle or a spiro ring substituted N -(2-Chloro-6-methylphenyl)-2[(2-methylpyrimidin-4-yl)amino]thiazole-5-carboxamide compound, its preparation method and its application in medicine. Background technique [0002] The prior art discloses that chronic myelogenous leukemia (CML) is a malignant clonal proliferative disease of the blood system that occurs in hematopoietic stem cells, and is also one of the four most common leukemias, accounting for about 15%-20% of leukemia cases , with an incidence rate of 1.6 / 100,000, which can occur in all age groups, and is most common in middle-aged and elderly cases. According to reports, in the United States, there are about 5,000 new cases of...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D491/107C07D495/10C07D417/14C07D487/10A61K31/506A61P35/00A61P35/02
CPCC07D417/14C07D487/10C07D491/107C07D495/10
Inventor 董肖椿赵伟利赵逸超林赵虎陆秀宏王雯董潜
Owner FUDAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com